Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2 Plasma cell 1 Other solid neoplasm 1 Gynecologic 1 CNS 1

Conditions

Thrombocytopenia 1 Glioblastoma 1

Interventions

Temozolomide 80 Radiotherapy 41 Bevacizumab 35 Radiosurgery 23 Magnetic Resonance Spectroscopy 20 Cyclophosphamide 17 Radiation 14 Irinotecan 13 Carboplatin 12 Topotecan 11 Nivolumab 11 Lomustine 11 Filgrastim 10 Everolimus 10 Etoposide 10 Erlotinib Hydrochloride 10 pembrolizumab 9 Radiotherapy, Intensity-Modulated 9 Ipilimumab 9 Granulocyte Colony-Stimulating Factor 8 Carmustine 8 antineoplaston AS 2-1 7 antineoplaston A10 7 Surgical Procedures, Operative 7 Mental Status and Dementia Tests 7 Isotretinoin 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 sargramostim 6 Vincristine 6 TPI-287 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × romiplostim × CNS × Clear all

NCT02227576 2018-04-25

PLATUM

University Hospital, Lille

Phase 2 Terminated

CNSClassical hematology

Glioblastoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡